Blocking nidogen-2 enhances chemotherapy efficacy in pancreatic cancer

FHS
July 9, 2024
6:50 pm

Researchers at the Garvan Institute of Medical Research have identified a potential new therapeutic target for pancreatic cancer, one of the most lethal cancer types with limited treatment options.

Porvair Sciences Introduces UltraPPM LITE for Reliable Sample Processing

Porvair Sciences is proud to announce the launch of its UltraPPM LITE positive pressure manifold.

November 13, 2023

Opinion | I Didn’t Truly Understand Opioid Addiction Until It Killed My Son

Baker is president of the Massachusetts Society of Addiction Medicine and an assistant professor of medicine. Over many years, I have resuscitated countless numbers of

May 8, 2024

Boehringer Ingelheim touts 10-year plan as it eyes overtaking Bayer as Germany’s largest pharma

Boehringer Ingelheim put the spotlight on a pipeline ripe with milestones over the next decade during its full-year 2023 call with the press. Driven in

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.